Posts Posts by: "Sean Ward"

The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking from the World Economic Forum, Sustainable Development Impact Summit, CEO Tim Fell stresses the need to make biology a true engineering discipline Funding to support strategic partnership initiatives and extensively scale sales and marketing LONDON…(Read More)

• World Economic Forum today announced its selection of the world’s 30 most promising Technology Pioneers 2016 at the Annual Meeting of the New Champions in Tianjin, People’s Republic of China • Synthace is the only UK company to have been selected • Companies were selected for their potential to significantly impact business and society…(Read More)

Synthace, the applied synthetic biology company developing high value chemical and biological products, announces that it has closed a funding round raising £1.3 Million. Sofinnova Partners’ Green Seed Fund led the financing, joined by a syndicate of angel investors. Synthace is applying its world leading platform of technologies to rapidly engineer and optimise novel…(Read More)

Eight synthetic biology (synbio) companies have joined the BioIndustry Association (BIA) to form a new group working on this emerging area of bioscience. Synbio is the design and engineering of biologically based parts, novel devices and systems as well as the redesign of existing, natural biological systems. It has the potential to deliver important new…(Read More)

Today Synthace announced the receipt of a highly competitive Technology Strategy Board award, ‘Rapid Engineering of Cellular Factories’, in collaboration with University College London and University of Manchester. Synthetic biology is an emerging, multidisciplinary approach at the intersection of engineering, bioscience, chemistry, and information technology, and builds atop many areas of innovation that the UK…(Read More)